Thomas Liu

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

Michael J. Koren, Robert C. Scott, Jae B. Kim et al. · The Lancet · 2012 · 362 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia

Michael J. Koren, Robert P. Giugliano, Frederick J. Raal et al. · Circulation · 2013 · 216 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Walter Offen, Christy Chuang‐Stein, Alex Dmitrienko et al. · Drug Information Journal · 2007 · 125 citations · Full text

Medicine, Biostatistics, Pharmacology +14

Efficient Norovirus and Reovirus Replication in the Mouse Intestine Requires Microfold (M) Cells

Mariam B. Gonzalez-Hernandez, Thomas Liu, Hilary C. Payne et al. · Journal of Virology · 2014 · 108 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients

Nihar R. Desai, Robert P. Giugliano, Jing Zhou et al. · Journal of the American College of Cardiology · 2013 · 52 citations

Pharmacy, Cardiology, Pharmacotherapy +15